Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
2015 · Clinical Cancer Research · 156 citations
https://doi.org/10.1158/1078-0432.ccr-14-2793
H
Hiroshi Ida
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
172
Papers
3.4K
Citations
32
h-index
65
i10-index
Hiroshi Ida is an academic researcher from Kindai University Hospital. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Hepatitis C virus research. The author has an h-index of 32, co-authored 147 publications.
ORCID: 0000-0002-0690-8218Papers by this author
worksAchievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study
2023 · Liver Cancer · 127 citations
https://doi.org/10.1159/000529574
Clinicopathological analysis of hepatic immune-related adverse events in comparison with autoimmune hepatitis and graft-versus host disease
2021 · Scientific Reports · 21 citations
https://doi.org/10.1038/s41598-021-88824-1
Supplementary Material for: MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.4476227
Supplementary Material for: Association between Genetic and Immunological Background of Hepatocellular Carcinoma and Expression of Programmed Cell Death-1
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.11968224
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat